Cost-effectiveness, budget impact, disease state modeling...

Products and Services

MDM develops medical decision models that are based on the research, interpretation, compilation, and incorporation of data and algorithms from a variety of scientifically-defensible sources. These sources include clinical trial, healthcare claims, epidemiological, and market data; and published meta-analyses and decision models from peer-reviewed medical journals. A key characteristic of all MDM-developed models is their flexibility to allow modifications of input data and assumptions related to effectiveness, costs, and population demographics. This allows the models to be credibly utilized both by marketers of pharmaceutical products and medical devices, as well as by their potential customers.

MDM specializes in the development of budget impact, cost-effectiveness, and disease progression models. Specifically, MDM is a leader in the development of healthcare-related discrete-event and microsimulation models utilizing its decades of engineering experience. MDM's model outputs typically include estimates of treatment and disease costs, market size and market share of these treatment, patient life expectancy (both with and without quality-adjustment), complication and mortality rates, and numerous cost-effectiveness measures. Depending on the requirements of the user, the decision models will output data for specified heterogeneous or homogeneous populations of patients as well as for individual patients.